Xylem (NYSE:XYL) Cut to Hold at ValuEngine

Xylem (NYSE:XYL) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Monday, February 4th.

Other analysts also recently issued research reports about the stock. Stifel Nicolaus raised shares of Xylem from a “hold” rating to a “buy” rating and upped their price target for the company from $72.00 to $75.00 in a report on Wednesday, December 19th. Boenning Scattergood reaffirmed a “buy” rating and set a $82.00 price target on shares of Xylem in a research report on Monday, November 19th. Seaport Global Securities set a $80.00 price target on shares of Xylem and gave the stock a “buy” rating in a research report on Wednesday, October 31st. Royal Bank of Canada reaffirmed a “buy” rating and set a $77.00 price target on shares of Xylem in a research report on Wednesday, October 31st. Finally, Oppenheimer reaffirmed a “buy” rating on shares of Xylem in a research report on Tuesday, October 30th. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the stock. Xylem currently has an average rating of “Buy” and a consensus target price of $78.36.

XYL stock traded up $0.82 during trading on Monday, reaching $76.37. 870,599 shares of the company were exchanged, compared to its average volume of 961,034. The company has a market cap of $13.44 billion, a P/E ratio of 25.88, a P/E/G ratio of 1.29 and a beta of 1.21. Xylem has a 52-week low of $60.65 and a 52-week high of $82.44. The company has a current ratio of 1.51, a quick ratio of 1.08 and a debt-to-equity ratio of 0.74.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, January 31st. The industrial products company reported $0.88 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.88. Xylem had a net margin of 10.54% and a return on equity of 19.89%. The company had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.36 billion. On average, equities research analysts expect that Xylem will post 3.31 earnings per share for the current year.

In other Xylem news, insider Kenneth Napolitano sold 35,526 shares of the firm’s stock in a transaction dated Monday, February 4th. The shares were sold at an average price of $70.17, for a total transaction of $2,492,859.42. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Tomas Brannemo sold 2,621 shares of the firm’s stock in a transaction dated Tuesday, February 26th. The shares were sold at an average price of $75.05, for a total transaction of $196,706.05. Following the transaction, the senior vice president now directly owns 12,774 shares in the company, valued at approximately $958,688.70. The disclosure for this sale can be found here. Insiders have sold a total of 38,706 shares of company stock worth $2,731,177 over the last quarter. 0.81% of the stock is currently owned by insiders.

Institutional investors have recently added to or reduced their stakes in the business. Doyle Wealth Management acquired a new position in shares of Xylem in the 4th quarter worth approximately $36,000. CWM LLC boosted its holdings in shares of Xylem by 100.9% in the fourth quarter. CWM LLC now owns 681 shares of the industrial products company’s stock worth $45,000 after buying an additional 342 shares during the period. Meeder Asset Management Inc. boosted its holdings in shares of Xylem by 5,057.1% in the fourth quarter. Meeder Asset Management Inc. now owns 722 shares of the industrial products company’s stock worth $48,000 after buying an additional 708 shares during the period. Essex Savings Bank acquired a new position in shares of Xylem in the fourth quarter worth about $53,000. Finally, Resources Investment Advisors Inc. acquired a new position in shares of Xylem in the fourth quarter worth about $57,000. 84.01% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Featured Article: What is the NASDAQ Stock Market?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.